XML 124 R62.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (FY) (Details) - USD ($)
2 Months Ended 9 Months Ended 12 Months Ended
Feb. 28, 2018
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Sep. 30, 2017
Effective Federal Income Tax Rate Reconciliation [Abstract]              
Federal statutory rate   21.00%   34.00% 34.00% 34.00%  
State taxes       1.10% 1.20% 2.90%  
Change in Statutory Rate       (25.60%) (0.00%) (0.00%)  
Permanent differences       (11.00%) (10.60%) (5.80%)  
Research and development       21.20% 16.00% 14.30%  
State taxes/ sale of NOL       4.80% 4.50% 3.80%  
Valuation allowance       (19.70%) (40.60%) (45.80%)  
Other       0.00% 0.00% 0.40%  
Effective tax rate       4.80% 4.50% 3.80%  
Deferred Tax Assets [Abstract]              
Federal net operating losses       $ 21,312,121 $ 23,644,647    
State net operating losses       2,268,249 1,554,730    
Stock options       1,608,750 1,419,494    
Amortization       612,878 69,529    
Accrued expense       7,027 2,731    
Other       30,999 18,042    
Total gross deferred tax assets       50,285,007 39,772,295    
Less valuation allowance       (50,285,007) (39,772,295)    
Net deferred tax assets       0 0    
Tax Cuts and Jobs Act [Abstract]              
Reduction in deferred tax assets   $ 13,600,000          
Income Tax Uncertainties [Abstract]              
Uncertain tax positions       0      
Income Tax Uncertainties [Abstract]              
Unrecognized tax benefits   0          
Accrued interest and penalties   $ 0         $ 0
Federal [Member]              
Tax Carryforwards [Abstract]              
Net operating loss carryforwards       $ 101,500,000      
Income Tax Uncertainties [Abstract]              
Tax year under examination       2015      
Unrecognized tax benefits       $ 0      
Accrued interest and penalties       $ 0      
Federal [Member] | Minimum [Member]              
Tax Carryforwards [Abstract]              
Expiration date of net operating loss carryforwards   Dec. 31, 2029   Dec. 31, 2029      
Federal [Member] | Maximum [Member]              
Tax Carryforwards [Abstract]              
Expiration date of net operating loss carryforwards   Dec. 31, 2037   Dec. 31, 2037      
New Jersey [Member]              
Tax Carryforwards [Abstract]              
Net operating loss carryforwards       $ 31,900,000      
NOL's sold       26,097,607 19,196,765    
Proceeds from sale of NOL's and R&D tax credits       $ 2,586,057 1,845,986    
New Jersey [Member] | Minimum [Member]              
Tax Carryforwards [Abstract]              
Expiration date of net operating loss carryforwards   Dec. 31, 2030   Dec. 31, 2030      
New Jersey [Member] | Maximum [Member]              
Tax Carryforwards [Abstract]              
Expiration date of net operating loss carryforwards   Dec. 31, 2037   Dec. 31, 2037      
Federal [Member]              
Deferred Tax Assets [Abstract]              
Tax credits       $ 24,060,243 12,709,438    
State [Member]              
Deferred Tax Assets [Abstract]              
Tax credits       384,740 353,684    
Research and Development Credit [Member] | Federal [Member]              
Tax Carryforwards [Abstract]              
Tax credit carryforwards       1,900,000      
Research and Development Credit [Member] | New Jersey [Member]              
Tax Carryforwards [Abstract]              
Tax credit carryforwards       400,000      
Tax credit carryforwards sold       424,466 $ 257,222    
Orphan Drug Credit [Member] | Federal [Member]              
Tax Carryforwards [Abstract]              
Tax credit carryforwards       $ 22,100,000      
Plan [Member]              
Effective Federal Income Tax Rate Reconciliation [Abstract]              
Federal statutory rate     21.00%        
Forecast [Member]              
Tax Cuts and Jobs Act [Abstract]              
Reduction in deferred tax assets $ 13,600,000